Home / China

Stem-cell trials give new hope to heart patients

By Shan Juan | China Daily | Updated: 2014-08-26 06:53

China's patients with chronic heart failure - a serious and common condition in which the heart cannot pump enough blood - will soon have access to the stem-cell-based therapy C-Cure.

Eight to 10 trial sites are expected to be set up at renowned public medical institutions in Beijing, Shanghai and Guangzhou, in addition to others around the world, to test the safety and effectiveness of the therapy.

"Participating in the trial will enhance the stem-cell research capacity of China, which remains uncompetitive worldwide," said Zhou Yujie, vice-president of Beijing Anzhen hospital.

Stem-cell trials give new hope to heart patients

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349